The associations of atrial fibrillation with the risks of incident invasive breast and colorectal cancers

Sylvia Wassertheil-Smoller, Aileen P. McGinn, Lisa Martin, Beatriz L. Rodriguez, Marcia L. Stefanick, Marco Perez

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is a common arrhythmia that poses a significant risk of stroke. Cross-sectional and casecontrol studies have shown evidence of associations between AF and breast or colorectal cancer, but there have been no longitudinal studies in which this has been assessed. We prospectively examined a cohort of 93,676 postmenopausal women enrolled in the Women's Health Initiative from 1994 to 1998 to determine whether there are relationships between baseline AF and the development of invasive breast or colorectal cancer. The prevalence of self-reported physician diagnosis of AF at baseline was 5.1%. Over approximately 15 years of follow-up, the incidence of invasive breast cancer was 5.7%, and the incidence of colorectal cancer was 1.6%. Adjusted hazard ratios and 95% confidence intervals were obtained using Cox proportional hazards models. We found no significant association between AF and incident colorectal cancer, but we did see a 19% excess risk of invasive breast cancer among those with AF (adjusted hazard ratio (HR) = 1.19, 95% confidence interval (CI): 1.03, 1.38). Additional adjustment for baseline use of cardiac glycosides attenuated the association between AF and invasive breast cancer (HR = 1.01, 95% CI: 0.85, 1.20). Cardiac glycoside use was strongly associated with incident invasive breast cancer (HR = 1.68, 95% CI: 1.33, 2.12) independent of AF and other confounders. Mechanisms of the associations among breast cancer, AF, and cardiac glycosides need further investigation.

Original languageEnglish (US)
Pages (from-to)372-384
Number of pages13
JournalAmerican Journal of Epidemiology
Volume185
Issue number5
DOIs
StatePublished - 2017

Fingerprint

Atrial Fibrillation
Colorectal Neoplasms
Breast Neoplasms
Cardiac Glycosides
Confidence Intervals
Incidence
Women's Health
Proportional Hazards Models
Longitudinal Studies
Cardiac Arrhythmias
Cross-Sectional Studies
Stroke
Physicians

Keywords

  • Atrial fibrillation
  • Breast cancer
  • Cardiac glycosides
  • Colorectal cancer
  • Digoxin

ASJC Scopus subject areas

  • Epidemiology

Cite this

The associations of atrial fibrillation with the risks of incident invasive breast and colorectal cancers. / Wassertheil-Smoller, Sylvia; McGinn, Aileen P.; Martin, Lisa; Rodriguez, Beatriz L.; Stefanick, Marcia L.; Perez, Marco.

In: American Journal of Epidemiology, Vol. 185, No. 5, 2017, p. 372-384.

Research output: Contribution to journalArticle

Wassertheil-Smoller, Sylvia ; McGinn, Aileen P. ; Martin, Lisa ; Rodriguez, Beatriz L. ; Stefanick, Marcia L. ; Perez, Marco. / The associations of atrial fibrillation with the risks of incident invasive breast and colorectal cancers. In: American Journal of Epidemiology. 2017 ; Vol. 185, No. 5. pp. 372-384.
@article{ffc0996ddc72472fae31435988c90dbd,
title = "The associations of atrial fibrillation with the risks of incident invasive breast and colorectal cancers",
abstract = "Atrial fibrillation (AF) is a common arrhythmia that poses a significant risk of stroke. Cross-sectional and casecontrol studies have shown evidence of associations between AF and breast or colorectal cancer, but there have been no longitudinal studies in which this has been assessed. We prospectively examined a cohort of 93,676 postmenopausal women enrolled in the Women's Health Initiative from 1994 to 1998 to determine whether there are relationships between baseline AF and the development of invasive breast or colorectal cancer. The prevalence of self-reported physician diagnosis of AF at baseline was 5.1{\%}. Over approximately 15 years of follow-up, the incidence of invasive breast cancer was 5.7{\%}, and the incidence of colorectal cancer was 1.6{\%}. Adjusted hazard ratios and 95{\%} confidence intervals were obtained using Cox proportional hazards models. We found no significant association between AF and incident colorectal cancer, but we did see a 19{\%} excess risk of invasive breast cancer among those with AF (adjusted hazard ratio (HR) = 1.19, 95{\%} confidence interval (CI): 1.03, 1.38). Additional adjustment for baseline use of cardiac glycosides attenuated the association between AF and invasive breast cancer (HR = 1.01, 95{\%} CI: 0.85, 1.20). Cardiac glycoside use was strongly associated with incident invasive breast cancer (HR = 1.68, 95{\%} CI: 1.33, 2.12) independent of AF and other confounders. Mechanisms of the associations among breast cancer, AF, and cardiac glycosides need further investigation.",
keywords = "Atrial fibrillation, Breast cancer, Cardiac glycosides, Colorectal cancer, Digoxin",
author = "Sylvia Wassertheil-Smoller and McGinn, {Aileen P.} and Lisa Martin and Rodriguez, {Beatriz L.} and Stefanick, {Marcia L.} and Marco Perez",
year = "2017",
doi = "10.1093/aje/kww185",
language = "English (US)",
volume = "185",
pages = "372--384",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - The associations of atrial fibrillation with the risks of incident invasive breast and colorectal cancers

AU - Wassertheil-Smoller, Sylvia

AU - McGinn, Aileen P.

AU - Martin, Lisa

AU - Rodriguez, Beatriz L.

AU - Stefanick, Marcia L.

AU - Perez, Marco

PY - 2017

Y1 - 2017

N2 - Atrial fibrillation (AF) is a common arrhythmia that poses a significant risk of stroke. Cross-sectional and casecontrol studies have shown evidence of associations between AF and breast or colorectal cancer, but there have been no longitudinal studies in which this has been assessed. We prospectively examined a cohort of 93,676 postmenopausal women enrolled in the Women's Health Initiative from 1994 to 1998 to determine whether there are relationships between baseline AF and the development of invasive breast or colorectal cancer. The prevalence of self-reported physician diagnosis of AF at baseline was 5.1%. Over approximately 15 years of follow-up, the incidence of invasive breast cancer was 5.7%, and the incidence of colorectal cancer was 1.6%. Adjusted hazard ratios and 95% confidence intervals were obtained using Cox proportional hazards models. We found no significant association between AF and incident colorectal cancer, but we did see a 19% excess risk of invasive breast cancer among those with AF (adjusted hazard ratio (HR) = 1.19, 95% confidence interval (CI): 1.03, 1.38). Additional adjustment for baseline use of cardiac glycosides attenuated the association between AF and invasive breast cancer (HR = 1.01, 95% CI: 0.85, 1.20). Cardiac glycoside use was strongly associated with incident invasive breast cancer (HR = 1.68, 95% CI: 1.33, 2.12) independent of AF and other confounders. Mechanisms of the associations among breast cancer, AF, and cardiac glycosides need further investigation.

AB - Atrial fibrillation (AF) is a common arrhythmia that poses a significant risk of stroke. Cross-sectional and casecontrol studies have shown evidence of associations between AF and breast or colorectal cancer, but there have been no longitudinal studies in which this has been assessed. We prospectively examined a cohort of 93,676 postmenopausal women enrolled in the Women's Health Initiative from 1994 to 1998 to determine whether there are relationships between baseline AF and the development of invasive breast or colorectal cancer. The prevalence of self-reported physician diagnosis of AF at baseline was 5.1%. Over approximately 15 years of follow-up, the incidence of invasive breast cancer was 5.7%, and the incidence of colorectal cancer was 1.6%. Adjusted hazard ratios and 95% confidence intervals were obtained using Cox proportional hazards models. We found no significant association between AF and incident colorectal cancer, but we did see a 19% excess risk of invasive breast cancer among those with AF (adjusted hazard ratio (HR) = 1.19, 95% confidence interval (CI): 1.03, 1.38). Additional adjustment for baseline use of cardiac glycosides attenuated the association between AF and invasive breast cancer (HR = 1.01, 95% CI: 0.85, 1.20). Cardiac glycoside use was strongly associated with incident invasive breast cancer (HR = 1.68, 95% CI: 1.33, 2.12) independent of AF and other confounders. Mechanisms of the associations among breast cancer, AF, and cardiac glycosides need further investigation.

KW - Atrial fibrillation

KW - Breast cancer

KW - Cardiac glycosides

KW - Colorectal cancer

KW - Digoxin

UR - http://www.scopus.com/inward/record.url?scp=85019739617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019739617&partnerID=8YFLogxK

U2 - 10.1093/aje/kww185

DO - 10.1093/aje/kww185

M3 - Article

C2 - 28174828

AN - SCOPUS:85019739617

VL - 185

SP - 372

EP - 384

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 5

ER -